New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 22, 2014
06:08 EDTCNCCentene reports Q1 EPS ex-items 79c, consensus 44c
Reports Q1 revenue $3.46B, consensus $3.25B. Reports diluted EPS of 79c excluding 16c of net cost associated with the health insurer fee and 6c of U.S. Medical Management acquisition transaction costs. Michael F. Neidorff, Centene's chairman and CEO, stated, "The company continues to diversify and add capabilities to the business, driving significant revenue and earnings growth year over year in Q1. Our guidance increase is driven by strong Q1 results across all metrics providing positive momentum for the remainder of the year."
News For CNC From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 17, 2014
10:51 EDTCNCLeerink healthcare services analyst holds analyst/industry conference call
Healthcare Services Analyst Gupte provides outlook and favorite names for 2015 in the Hospitals and Managed Care Industry on an Analyst/Industry conference call to be held on December 18 at 1 pm.
December 16, 2014
08:13 EDTCNCCentene price target raised to $125 from $108 at Cantor
Subscribe for More Information
07:57 EDTCNCCentene price target raised to $118 from $102 at Credit Suisse
Subscribe for More Information
December 15, 2014
08:41 EDTCNCCentene price target raised to $120 from $100 at Leerink
Subscribe for More Information
December 12, 2014
06:06 EDTCNCCentene sees FY15 EPS $5.05-$5.35, consensus $4.92
Sees FY15 premium and service revenues $20.3B-$20.8B.
06:05 EDTCNCCentene backs FY14 EPS view of $4.35-$4.50, consensus $4.28
Subscribe for More Information
December 10, 2014
14:45 EDTCNCDeal would block payments to health insurance companies, The Hill says
Subscribe for More Information
December 9, 2014
10:31 EDTCNCCentene to host investor meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use